FIELD: pharmaceutics.
SUBSTANCE: invention relates to aqueous liquid pharmaceutical compositions for inhalation containing arbekacine and chloride-ions. Invention relates to use of aqueous liquid composition for inhalation for treating or preventing diseases of upper or lower airways, as well as arbekacine hydrochloride.
EFFECT: compositions are well accepted, while using in method of treating or preventing diseases of upper or lower airways, in which aerosol composition is inhaled by patient.
13 cl, 11 ex, 2 dwg, 15 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED PREPARATIONS OF AMINOGLYCOSIDES AND PHOSPHOMYCIN, HAVING IMPROVED CHEMICAL PROPERTIES | 2014 |
|
RU2691658C2 |
TREATMENT OF PULMONARY INFECTIONS BY ADMINISTERING TOBRAMYCIN BY AEROLYSATION | 2011 |
|
RU2597842C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
IPRATROPIUM BROMIDE SOLUTION | 2012 |
|
RU2496477C1 |
SET FOR PHARMACEUTICAL COMPOSITION PREPARING | 2002 |
|
RU2279292C2 |
INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
LIQUID PREPARATION CONTAINING TOBRAMYCINE | 2004 |
|
RU2341267C2 |
Authors
Dates
2016-12-10—Published
2012-08-03—Filed